Will new drugs change the standard of care for patients with mantle cell lymphoma? - Test2 - elhamkhani - TriplyDB

Will new drugs change the standard of care for patients with mantle cell lymphoma?

Will new drugs change the standard of care for patients with mantle cell lymphoma?

http://www.wikidata.org/entity/Q38658549

about

Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK's Haematological Malignancy Research Network (HMRN).

P2860

Q52658547-598BD18D-997F-4C2C-9072-8DDB49CB48F5

P2860

Will new drugs change the standard of care for patients with mantle cell lymphoma?

http://www.wikidata.org/entity/Q38658549

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Will new drugs change the standard of care for patients with mantle cell lymphoma?

@en

type

label

Will new drugs change the standard of care for patients with mantle cell lymphoma?

@en

prefLabel

Will new drugs change the standard of care for patients with mantle cell lymphoma?

@en

P1433

Q38658549-A9BBB1EB-7E11-4CA3-B42C-905475B37376

P1476

Q38658549-5A3A4070-D958-4CF0-8032-F27238E4347F

P2093

Q38658549-0478EBB6-3436-4CE5-A9A8-A7D5687D3891

Q38658549-0DF01B5E-C33D-4446-B79F-F556DDEE65F7

Q38658549-6001B166-9467-484D-AF34-DA0D3FBB9A49

Q38658549-B7E0C371-A98D-4418-A9EB-AF5B936C9469

Q38658549-BA88D825-06E3-4687-8182-1A0C9C0C0F55

P2860

Q38658549-019F17E5-7F57-4536-9FAF-B9C803EC34DA

Q38658549-0E9A476E-68D3-404B-BC6A-78C8FB4874FF

Q38658549-1747DF8B-53A8-4982-9A60-73C76DDE2DB2

Q38658549-222CF602-F427-4745-A311-4092010C02C0

Q38658549-373DDBAF-045E-4ED1-9D1D-64450A8BCABD

Q38658549-42F6CF37-0128-43A7-8CFF-B5502C0D7558

Q38658549-44B154FA-7F75-4D8E-AB89-ABFA1ADE3D33

Q38658549-48B058BB-C6FB-4A49-979D-FA7BF5CF2D19

Q38658549-4C344223-E22A-4810-A5B1-E62E2F033431

Q38658549-4EA39CCA-105F-4AEC-94D5-F955E71AD408

P304

Q38658549-7F546F2F-DFE0-4FEF-9417-6BF425E96DD2

P31

Q38658549-AA9326D0-3FA3-4C23-B02C-9ACE694AC356

P356

Q38658549-61CF249E-D3AE-47CF-91EB-FB0C386083E2

P433

Q38658549-20F35B5C-893B-43F6-8371-702DE813546F

P478

Q38658549-261AA19A-6712-4A49-8D6F-511AC1E69113

P577

Q38658549-6D837715-DB7D-442E-BD5E-8D3EEFE1ED44

P698

Q38658549-95A2C3FF-F2E9-48B8-B3F7-C8582FA60E56

P356

14737140.2016.1127761

P1433

Expert Review of Anticancer Therapy

P1476

Will new drugs change the standard of care for patients with mantle cell lymphoma?

@en

P2093

Ahmed Sawas

http://www.w3.org/2001/XMLSchema#string

Changchun Deng

http://www.w3.org/2001/XMLSchema#string

Donald S Colbourn

http://www.w3.org/2001/XMLSchema#string

Jennifer E Amengual

http://www.w3.org/2001/XMLSchema#string

Owen A O'Connor

http://www.w3.org/2001/XMLSchema#string

P2860

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma.

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma.

Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma.

Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study.

Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma.

Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group.

The activation of Akt/PKB signaling pathway and cell survival.

P304

199-210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.2016.1127761

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26634782

http://www.w3.org/2001/XMLSchema#string